Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management
Main Authors: | Christine Sempoux, Montserrat Fraga, Julien Vionnet, Alexander Coukos |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-02-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/2/e006877.full |
Similar Items
-
Better understanding of ICI-induced cholangitis for better management
by: Alexandre Maria, et al.
Published: (2023-02-01) -
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
by: Solange Peters, et al.
Published: (2022-10-01) -
Letter to the Editor: Strengthening the Disaster Response of the Philippines for a Better Healthcare System
by: Dalmacito A. Cordero
Published: (2023-03-01) -
Letter to Editor: An inquest into alpha-2 agonists as a better adjuvant to intrathecal bupivacaine
by: Imran Ahmed Khan, et al.
Published: (2023-09-01) -
Immune checkpoint therapy in colorectal cancer: is first better than last?
by: Yui Kaneko, et al.
Published: (2023-10-01)